- Therapeutic Plasmapheresis Enabling Radioactive Iodine Treatment in a Patient with Thyrotoxicosis
-
Min SH, Phung A, Oh TJ, Han KS, Kim MJ, Kim JM, Lee JH, Park YJ
- KMID: 2344190
- J Korean Med Sci.
- 2015 Oct;30(10):1531-1534.
- doi: 10.3346/jkms.2015.30.10.1531
Therapeutic plasma exchange (TPE) is one possible treatment for patients resistant to conventional antithyroid drugs or requiring urgent attention for thyrotoxicosis. We report a 35-yr-old man with thyrotoxicosis, ultimately attributed... -
- CITED
-
- Close
- SHARE
-
- Close
- Lesionalized Therapy beyond Personalized Therapy in Cancer Management
-
Chung JK, Kim MJ, Youn H
- KMID: 2129621
- J Korean Med Sci.
- 2014 Oct;29(10):1331-1332.
- doi: 10.3346/jkms.2014.29.10.1331
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The Effectiveness of Recombinant Human Thyroid-Stimulating Hormone versus Thyroid Hormone Withdrawal Prior to Radioiodine Remnant Ablation in Thyroid Cancer: A Meta-Analysis of Randomized Controlled Trials
-
Pak K, Cheon GJ, Kang KW, Kim SJ, Kim IJ, Kim EE, Lee DS, Chung JK
- KMID: 1796944
- J Korean Med Sci.
- 2014 Jun;29(6):811-817.
- doi: 10.3346/jkms.2014.29.6.811
We evaluated the efficacy of recombinant human thyroid-stimulating hormone (rhTSH) versus thyroid hormone withdrawal (THW) prior to radioiodine remnant ablation (RRA) in thyroid cancer. A systematic search of MEDLINE, EMBASE,... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid Cancer
-
Ha S, Oh SW, Kim YK, Koo DH, Jung YH, Yi KH, Chung JK
- KMID: 2164471
- J Korean Med Sci.
- 2015 Jul;30(7):876-881.
- doi: 10.3346/jkms.2015.30.7.876
Radioiodine activity required for remnant thyroid ablation is of great concern, to avoid unnecessary exposure to radiation and minimize adverse effects. We investigated clinical outcomes of remnant thyroid ablation with... -
- CITED
-
- Close
- SHARE
-
- Close
